Global Blood Therapeutics Inc.

06/11/2021 | Press release | Distributed by Public on 06/11/2021 01:06

New Data Supporting the Potential Use of Oxbryta® (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual[...]